BiotechTube
Home/Soligenix/Christopher J. Schaber, PhD
CJ

Christopher J. Schaber, PhD

President, Chief Executive Officer, Director

Soligenix

Therapeutic Areas

OncologyInflammation/ImmunologyInfectious DiseaseBiodefense

Soligenix Pipeline

DrugIndicationPhase
SGX301Cutaneous T-Cell Lymphoma (CTCL)Phase 3
SGX942Oral Mucositis in Head & Neck CancerPhase 3
SGX945Behçet's Disease (Oral Ulcers)Phase 2a
SGX302Psoriasis (Plaque)Phase 2a
RiVax®Prevention of Ricin IntoxicationPhase 1b
SGX204Filovirus (Ebola/Marburg) VaccinePreclinical
Dengue VaccinePrevention of Dengue FeverPreclinical

Leadership Team at Soligenix

JL
Jonathan L. Guarino, CPA
Chief Financial Officer
OD
Oreola Donini, PhD
Senior Vice President, Chief Scientific Officer
RS
Richard Straube, MD
Senior Vice President, Chief Medical Officer
DL
Diane L. Parks
Vice President, Regulatory Affairs
View full Soligenix profile